What are the best treatments for Cushing Syndrome?

The primary goal for treating Cushing Syndrome is to normalize cortisol levels, with surgical removal of the underlying tumor remaining the first-line and curative treatment for most cases. When surgery is not an option or is unsuccessful, patients may utilize targeted medications or radiation therapy, all of which must be personalized by a multidisciplinary medical team to manage the complex systemic effects of excess cortisol.

What are the primary medical treatments for Cushing Syndrome?

For most patients diagnosed with Cushing Syndrome, surgery is the gold standard. If the condition is caused by a pituitary adenoma, transsphenoidal surgery is the preferred approach. If the tumor is located on the adrenal glands or elsewhere in the body (ectopic Cushing Syndrome), surgeons aim for complete resection of the tumor. When surgery cannot achieve a cure, or if a patient is not a surgical candidate, clinicians may turn to pharmacological interventions to control hypercortisolism or radiation therapy to reduce tumor size and hormone production.

Which medications are used to manage Cushing Syndrome?

When surgical options are exhausted or insufficient, several medical therapies are available to help manage Cushing Syndrome. These medications work by either blocking cortisol production in the adrenal glands or inhibiting the signals that trigger cortisol release. Commonly prescribed medications include:

• Steroidogenesis inhibitors: These drugs, such as ketoconazole, metyrapone, and osilodrostat (Isturisa), act directly on the adrenal glands to decrease cortisol synthesis.


• Pituitary-directed agents: Pasireotide (Signifor) is often used for patients with Cushing disease (pituitary-dependent Cushing Syndrome) to reduce the secretion of ACTH.


• Glucocorticoid receptor antagonists: Mifepristone (Korlym) blocks the effects of cortisol at the receptor level, which can be helpful for managing symptoms like hyperglycemia in patients with type 2 diabetes or glucose intolerance.

How does a multidisciplinary team manage Cushing Syndrome?

Because Cushing Syndrome affects nearly every organ system, a multidisciplinary approach is essential for comprehensive care. A typical care team should include an endocrinologist to oversee hormonal management, a neurosurgeon or general surgeon for tumor removal, and an oncology specialist if the condition is linked to ectopic tumors. Additionally, physical therapists play a vital role in regaining muscle strength lost during the period of hypercortisolism, while clinical psychologists or psychiatrists are crucial for managing the mood disorders, anxiety, and cognitive changes often associated with the disease.

What is the role of emerging treatments and clinical trials?

The landscape for treating Cushing Syndrome is evolving as researchers seek more targeted therapies that minimize side effects. Current clinical trials are investigating new, more selective cortisol-synthesis inhibitors and combination therapies designed to achieve biochemical control more rapidly. Researchers are also exploring the long-term impacts of pituitary-directed therapies to better understand their efficacy in preventing recurrence. Patients are encouraged to discuss ongoing trials listed on clinicaltrials.gov with their endocrinologist to determine if they are candidates for new, cutting-edge treatment protocols.

Next steps

• Consult with a board-certified endocrinologist who specializes in adrenal or pituitary disorders.


• Request a comprehensive evaluation of your bone density and cardiovascular health, as these are frequently impacted by Cushing Syndrome.


• Join the DiseaseMaps.org community to connect with 173 others who have navigated these treatment paths.


• Keep a symptom diary to help your care team track the effectiveness of your personalized treatment plan.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your physician for personalized treatment plans and dosage information.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Cushing Syndrome


• Orphanet: Rare Disease Database (Cushing Syndrome)


• The Pituitary Society: Guidelines for the Management of Cushing Disease


• Endocrine Society: Clinical Practice Guidelines for the Diagnosis and Treatment of Cushing Syndrome